Drug
Aeras 402
Aeras 402: highest development phase Phase 1, developed by Emergent BioSolutions. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Emergent BioSolutions
Trials
| Drug | Phase | Indication |
|---|---|---|
| AERAS-402 NCT01683773 | Phase 1 | Tuberculosis |
Latest
No recent events.
Follow Aeras 402 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.